Drug General Information |
Drug ID |
D0LU5Q
|
Former ID |
DIB006335
|
Drug Name |
TPM-1/Morphine
|
Indication |
Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89]
|
Phase 2 |
[1]
|
Company |
Phosphagenics
|
Target and Pathway |
Target(s) |
Kappa-type opioid receptor |
Target Info |
Inhibitor |
[2]
|
Delta-type opioid receptor |
Target Info |
Inhibitor |
[2]
|
Mu-type opioid receptor |
Target Info |
Inhibitor |
[2]
|
KEGG Pathway
|
Neuroactive ligand-receptor interactionhsa04022:cGMP-PKG signaling pathway
|
Sphingolipid signaling pathway
|
Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
|
Estrogen signaling pathway
|
Morphine addiction
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Enkephalin release
|
Opioid proenkephalin pathway
|
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Pathway Interaction Database
|
IL4-mediated signaling events
|
Reactome
|
Peptide ligand-binding receptors
|
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
|
G alpha (i) signalling events
|
WikiPathways
|
GPCRs, Class A Rhodopsin-like
|
Peptide GPCRs
|
GPCR ligand binding
|
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
|
GPCR downstream signalingWP69:TCR Signaling Pathway
|
Opioid Signalling
|
GPCR downstream signaling
|
References |
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023017) |
---|
REF 2 | Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Behavior. Anesthesiology. 2011 December; 115(6): 1363-1381. |